Apollomics
APLM • NASDAQ
Apollomics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Hung-Wen Chen, with a market cap of $37.1M.
CEOHung-Wen Chen
Next Earnings
Upcoming earnings announcement for Apollomics
Date
Friday, April 17, 2026 (in 1 week)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
FY 2025
Earnings History
Past 5 earnings reports for Apollomics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Dec 22, 2025 | H1 2025 | -$11.37 | — | $8.5K | — | — |
| Apr 3, 2025 | FY 2024 | -$52.80 | — | - | — | — |
| Aug 14, 2024 | H1 2024 | -$38.00 | — | - | — | — |
| Mar 28, 2024 | FY 2023 | -$232.00 | — | - | — | — |
| Sep 28, 2023 | H1 2023 | -$255.00 | — | - | — | — |